Logotype for Acme United Corporation

Acme United (ACU) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Acme United Corporation

Q4 2024 earnings summary

8 Jul, 2026

Executive summary

  • Achieved record net sales of $194.5 million and record EBITDA of $20 million for 2024, with net income rising 23% year-over-year to $10 million.

  • Sold Cuda and Camillus hunting and fishing business in November 2023 for $19.8 million, using $15 million after-tax proceeds to reduce debt and support growth.

  • Adjusted net revenues (excluding divested businesses) grew 6% in 2024; overall net sales grew 2% despite $9 million revenue loss from divestiture.

  • Elite First Aid acquisition in May 2024 for $6.1 million was fully integrated, supporting growth in first responder kits.

  • Productivity improvements and cost reductions offset lost contributions from divested businesses.

Financial highlights

  • Fourth quarter net sales were $45.9 million, up 10% year-over-year; full-year net sales reached $194.5 million, up 2%.

  • Gross margin for 2024 was 39.3%, up from 37.7% in 2023, driven by productivity improvements.

  • SG&A expenses for 2024 were $62 million (32% of sales), up from $59 million (31% of sales) in 2023, mainly due to inflation and wage increases.

  • Interest expense declined to $1.9 million from $3 million in 2023, reflecting lower average debt.

  • Earnings per share for 2024 were $2.45, up 10% from $2.23 in 2023.

Outlook and guidance

  • Management expects further growth in 2025, leveraging strong liquidity, customer base, and the Elite First Aid acquisition.

  • SG&A expected to remain between 31% and 32% of sales going forward.

  • Company anticipates challenges from tariffs in 2025 but feels well-prepared due to diversified sourcing and domestic production.

  • Plans to expand distribution and sales of first responder kits and pursue additional acquisitions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more